Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

A. De Remigis, T.D. de Gruijl, J.N. Uram, S.C. Tzou, S. Iwama, M.V. Talor, T.D. Armstrong, S.J.A.M. Santegoets, S.F. Slovin, L. Zheng, D.A. Laheru, E.M. Jaffee, W.R. Gerritsen, A.J.M. van den Eertwegh, D.T. Le, P. Caturegli

Research output: Contribution to journalArticleAcademicpeer-review

28 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)127-137
JournalInternational journal of cancer
Issue number1
Publication statusPublished - 2015

Cite this